Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial
Tom P. Freeman, Chandni Hindocha, Gianluca Baio, Natacha D. C. Shaban, Emily M Thomas, Danica Astbury, Abigail M. Freeman, Rachel Lees, Sam Craft, Paul D. Morrison, Michael Bloomfield, Dominic O’Ryan, Jane Kinghorn, Celia J. A. Morgan, Ali Mofeez, Valerie H. Curran
Topics & Concepts
CannabidiolPlaceboCannabisMedicineDouble blindBayesian probabilityPsychiatryPsychologyAlternative medicineComputer scienceArtificial intelligencePathologyCannabis and Cannabinoid ResearchSubstance Abuse Treatment and OutcomesPsychedelics and Drug Studies